Skip to main content

Table 2 Exposure to any TNFi by pediatric patients at CoA residing in Alabama

From: Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study

Characteristic

Value

n

1033

Age at initial usage (median, IQR)

13.0 (9.2–15.8)

Years of exposure (median, IQR)

1.0 (0.17–2.4)

Female

592 (57%)

Race

 Caucasian

771 (75%)

 African-American

251 (24%)

 Other / unknown

11 (1.1%)

Number of TNF inhibitors used

 1

768 (74%)

 2

227 (22%)

 3

37 (3.6%)

 4

1 (0.1%)

Diagnosis

 JIAa

544

 IBDa

265

 IBD with JIAa

69

 Vasculitis

33

 Uveitis

31

 Psoriasis

29

 Sarcoidosis

17

 Mixed connective tissue disease / SLE

13

 Sjogren Syndrome

7

 Recurrent fever syndrome

6

 Behcet Syndrome

5

 Hidradenitis

3

 Juvenile dermatomyositis

3

 Non-infectious osteomyelitis

3

 Sensorineural hearing loss

2

 Otherb

3

Cases of Tuberculosis

1

  1. Abbreviations: IBD inflammatory bowel disease, JIA Juvenile idiopathic arthritis, SLE systemic lupus erythematosus
  2. aIncludes subjects with uveitis, psoriasis, or both
  3. bIncludes one each of chronic granuloma annulare, pityriasis rubra pilaris, and orbital pseudotumor